Givaudan stock plunges after guidance concerns emerge from analyst call.

Shares in Givaudan experienced a significant downturn in trading on Thursday, following reports that traders were reacting negatively to comments made during an analyst call regarding sales guidance. The call, held in anticipation of the company's full-year results scheduled for release next month, raised concerns among investors about Givaudan's performance outlook.

The stock's movement reflected the sudden shift in investor sentiment. By 1051 GMT, Givaudan’s stock had fallen by more than 6%. This sharp decline marked a dramatic turnaround from earlier trading, where the stock had initially shown positive momentum, rising by 0.4% before the news of the guidance concerns emerged.

Market analysts attributed the stock drop primarily to Givaudan's failure to reaffirm its previously established full-year sales growth guidance. One trader specifically noted that the fragrance maker did not confirm the 5.5% sales growth target during the update call, leading to speculation that market conditions were proving more challenging than anticipated.

This sentiment was echoed by a note from Jefferies, which provided additional context on the situation. Jefferies wrote that Givaudan hosted a "group Q4 update" where it was indicated that "Market conditions more challenging versus the 5.5% OSG (Organic Sales Growth) guide provided in August." This analyst assessment reinforced concerns that the company's performance for the latter part of the year may not meet earlier expectations.

Despite the market reaction and analyst commentary, Givaudan itself has yet to provide an official statement regarding the guidance concerns. The company was not immediately available for comment, leaving investors to interpret the signals from the analyst call ahead of the official release of the full-year results next month.